Brief Title
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Official Title
Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Brief Summary
Hydrocephalus is a potentially debilitating neurological condition that primarily affects babies under a year of age and has traditionally been treated by inserting a shunt between the brain and the abdomen. A newer endoscopic procedure offers hope of shunt- free treatment that may reduce complications over a child's life, but it is not clear if the endoscopic procedure results in similar intellectual outcome as shunt. Therefore, the investigators propose a randomized trial to compare intellectual outcome and brain structural integrity between these two treatments, to help families make the best treatment decision for their baby.
Detailed Description
The ESTHI Trial is a multi-center randomized controlled trial (RCT) comparing endoscopic third ventriculostomy with choroid plexus cauterization (ETV+CPC) and shunt in infants with hydrocephalus. The study will leverage the infrastructure of the Hydrocephalus Clinical Research Network (HCRN), a committed group of 14 leading North American pediatric neurosurgical centers with a long track-record of successful collaborative clinical research and RCTs in hydrocephalus. Optimal cognitive outcome is the primary concern of families and will, therefore, be the primary outcome. Assessment of dMRI, a validated, non-invasive method of measuring white matter microstructural integrity and structural connectivity in the developing brain, will provide further insight into the developmental consequences of these two treatments. The results of the RCT will help families determine the optimal treatment of hydrocephalus for their child.
Study Phase
Phase 3
Study Type
Interventional
Primary Outcome
Bayley Scale of Infant Development-IV (Bayley-IV) Cognitive Scale score
Secondary Outcome
Bayley Scale of Infant Development-IV (Bayley-IV) Language Scaled Score
Condition
Hydrocephalus
Intervention
Endoscopic Third Ventriculostomy with Choroid Plexus Cauterization (ETV+CPC)
Study Arms / Comparison Groups
ETV+CPC
Description: Subjects randomized to this arm will undergo an ETV+CPC procedure for treatment of Hydrocephalus
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Procedure
Estimated Enrollment
176
Start Date
July 21, 2020
Completion Date
September 30, 2026
Primary Completion Date
January 30, 2024
Eligibility Criteria
Inclusion Criteria: 1. Corrected age <104 weeks and 0 days, AND 2. Child is ≥ 37 weeks post menstrual age, AND 3. Child must have symptomatic hydrocephalus, defined as: Ventriculomegaly on MRI (frontal-occipital horn ratio (FOR) >0.45, which approximates "moderate ventriculomegaly"), and at least one of the following: - Head circumference >98th percentile for corrected age with either bulging fontanelle or splayed sutures - Upgaze paresis/palsy (sundowning) - CSF leak - Papilledema - Tense pseudomeningocele or tense fluid along a track - Vomiting or irritability, with no other attributable cause - Bradycardias or apneas, with no other attributable cause - Intracranial pressure (ICP) monitoring showing persistent elevation of pressure with or without plateau waves AND 4. No prior history of shunt insertion or endoscopic third ventriculostomy (ETV) procedure (previous temporization devices and/or external ventricular drains permissible) Exclusion Criteria: 1. Hydrocephalus due to intraventricular hemorrhage in a child born before 37 weeks gestational age; OR 2. Anatomy not suitable for ETV+CPC or anteriorly placed ventriculoperitoneal shunt defined as: - Moderate to severe prepontine adhesions on steady state free precession (SSFP) or T2 weighted fast (turbo) spin echo (FSE/TSE) MRI, which includes the following sequences: FIESTA, FIESTA-C, TrueFISP, CISS, Balanced FFE (bFFE), CUBE, SPACE, VISTA, IsoFSE, and 3D MVOX - Closure of one or both foramina of Monro - Thick floor of third ventricle (≥ 3mm) - Narrow third ventricle (<5mm) - Presence of scalp, bone, or ventricular lesions that make placement of an anterior shunt impracticable; OR 3. Underlying condition with a high chance of mortality within 12 months; OR 4. Hydrocephalus with loculated CSF compartments; OR 5. Peritoneal cavity not suitable for distal shunt placement; OR 6. Active CSF infection; OR 7. Hydranencephaly; OR 8. Child requires an intraventricular procedure (e.g. endoscopic biopsy) in addition to the initial first-time permanent procedure for the treatment of hydrocephalus.
Gender
All
Ages
0 Days - 104 Weeks
Accepts Healthy Volunteers
No
Contacts
John Kestle, MD, 801-662-5344, [email protected]
Location Countries
Canada
Location Countries
Canada
Administrative Informations
NCT ID
NCT04177914
Organization ID
HCRN 012
Secondary IDs
1U01NS107486-01A1
Responsible Party
Principal Investigator
Study Sponsor
University of Utah
Collaborators
University of Alabama at Birmingham
Study Sponsor
John Kestle, MD, Study Chair, University of Utah
Verification Date
July 2022